Ninomiya Toshiharu, Perkovic Vlado, Verdon Christine, Barzi Federica, Cass Alan, Gallagher Martin, Jardine Meg, Anderson Craig, Chalmers John, Craig Jonathan C, Huxley Rachel
The George Institute for International Health, The University of Sydney, Sydney, Australia.
Am J Kidney Dis. 2009 Mar;53(3):417-25. doi: 10.1053/j.ajkd.2008.08.032. Epub 2008 Dec 13.
The associations between decreased kidney function and cardiovascular disease recently have been established. However, there is uncertainty about the consistency between the independent associations of proteinuria as a risk factor across all cardiovascular end points. We undertook a meta-analysis of published cohort studies to provide a reliable estimate of the strength of association between proteinuria and risk of stroke.
Meta-analysis of observational cohort studies.
SETTING & POPULATION: General population of participants with diabetes. Studies were excluded if participants had known glomerular disease or had undergone dialysis or transplantation.
MEDLINE, EMBASE, and CINAHL databases were searched for studies that reported age- or multivariate-adjusted risk ratio with some estimate of the variance of the association between proteinuria and risk of stroke, without language restriction.
Proteinuria or albuminuria.
Fatal or nonfatal stroke.
Data from 10 published studies involving 140,231 participants and 3,266 strokes were eligible for inclusion. Participants with proteinuria had a 71% greater risk of stroke compared with those without proteinuria (95% confidence interval, 1.39 to 2.10). There was evidence of significant quantitative heterogeneity in the magnitude of the association across studies (I(2) = 60%; P for heterogeneity = 0.008), which was partially explained by differences in methods for measuring proteinuria. The risk of stroke remained significant after adjustment for other vascular risk factors.
Because individual patient data were unavailable, we were unable to fully examine the impact of adjustment for known cardiovascular risk factors on the strength of the association between proteinuria and stroke risk. It is possible that the pooled estimate was affected by regression dilution bias.
These findings support the independent relationship between proteinuria and stroke. Additional studies are warranted to determine whether interventions to reduce proteinuria are effective at reducing rates of stroke.
肾功能下降与心血管疾病之间的关联最近已得到证实。然而,蛋白尿作为所有心血管终点风险因素的独立关联之间的一致性尚不确定。我们对已发表的队列研究进行了荟萃分析,以提供蛋白尿与中风风险之间关联强度的可靠估计。
观察性队列研究的荟萃分析。
糖尿病参与者的一般人群。如果参与者已知患有肾小球疾病或已接受透析或移植,则排除相关研究。
检索MEDLINE、EMBASE和CINAHL数据库,查找报告年龄或多变量调整风险比以及蛋白尿与中风风险之间关联方差估计值的研究,无语言限制。
蛋白尿或白蛋白尿。
致命或非致命性中风。
来自10项已发表研究的数据,涉及140231名参与者和3266例中风,符合纳入标准。与无蛋白尿者相比,有蛋白尿者中风风险高71%(95%置信区间,1.39至2.10)。有证据表明,各研究之间关联程度存在显著的定量异质性(I² = 60%;异质性P值 = 0.008),部分原因是蛋白尿测量方法不同。调整其他血管危险因素后,中风风险仍然显著。
由于无法获得个体患者数据,我们无法充分检验已知心血管危险因素调整对蛋白尿与中风风险关联强度的影响。汇总估计值可能受到回归稀释偏倚的影响。
这些发现支持蛋白尿与中风之间的独立关系。有必要进行更多研究,以确定降低蛋白尿的干预措施是否能有效降低中风发生率。